BRMS1 and cutaneous melanoma: In addition, in a third study, BRMS1 mRNA levels were measured in a panel of skin melanocyte- and melanoma-derived cell lines representing a continuum of skin melanoma stages of progression and it was found that mRNA levels decreased as the cell lines’ metastatic potential increased [25].